Dataset of STAT5A status in breast cancer

Utpal K Mukhopadhyay1, Jamaica Cass1, Leda Raptis1

  • 1Division of Cancer Biology and Genetics, Queen׳s University Cancer Research Institute, Kingston, Ontario, Canada K7L 3N6.

Data in Brief
|March 26, 2016
PubMed

Insights

Signal transducer and activator of transcription 5A (STAT5A) gene expression is generally downregulated in breast cancer, according to an analysis of four studies. This finding suggests STAT5A may play a role in breast cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Expression Analysis

Background:

  • Signal transducer and activator of transcription 5A (STAT5A) is a transcription factor involved in cell proliferation and differentiation.
  • Aberrant gene expression is a hallmark of cancer, including breast cancer.
  • Understanding gene expression patterns can provide insights into cancer mechanisms.

Purpose of the Study:

  • To analyze the expression levels of STAT5A in breast cancer tissues.
  • To investigate the potential role of STAT5A in breast cancer pathogenesis.

Main Methods:

  • Utilized the Oncomine database for comprehensive gene expression analysis.
  • Examined data from four distinct, representative studies on breast cancer.
  • Focused on STAT5A gene expression patterns across these studies.

Main Results:

  • STAT5A gene expression was found to be generally downregulated in breast cancer samples compared to normal tissues.
  • Consistent downregulation was observed across the four analyzed studies, indicating a robust trend.
  • This downregulation suggests STAT5A may function as a tumor suppressor in breast cancer.

Conclusions:

  • STAT5A downregulation is a common feature in breast cancer.
  • STAT5A may play a critical role in breast cancer development and progression.
  • Further research into STAT5A's function in breast cancer is warranted.